Latest Comments
-
adriabold on CYTORI (CYTX): A STEM CELL HOPE FOR URINARY INCONTINENCE it depends on what you mean by medical device.....
-
MCMBAHAMAS on Will LPATH (LPTN.OB) Reap the Fruits Of Its Acknowledged Efforts Good day SirsI just started a position this wee...
-
joebeckman07 on INSMED’S (INSM) DRUG IPLEX™: VALUABLE, OR NOT VALUABLE? <Insmed is run as a criminal enterprise by t...
-
DESMOND on SAVIENT: WHY KRYSTEXXA’S REWARD OUTWEIGHS THE RISK? I am very exicted about this new product, altho...
-
Obi.Wan on XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM? Do you believe XOMA is about to receive another...
Most Commented
- CYTORI (CYTX): A STEM CELL HOPE FOR URINARY INCONTINENCE (3 Comments)
- SAVIENT: WHY KRYSTEXXA’S REWARD OUTWEIGHS THE RISK? (2 Comments)
- INSMED’S (INSM) DRUG IPLEX™: VALUABLE, OR NOT VALUABLE? (2 Comments)
- XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM? (1 Comment)
- Will LPATH (LPTN.OB) Reap the Fruits Of Its Acknowledged Efforts (1 Comment)
Posts by Themes
Adventrix,
Allos Therapeutics,
Amgen,
ASONEP,
BioCryst,
Biotech,
biotech,
biotech stocks,
Biotech Stocks,
biotechnology,
Biotechnology,
biotechnology stocks,
Biotechnology Stocks,
Bitoech,
Cadence Pharmaceuticals,
Cancer drugs,
CGEN,
CompuGen,
Cytokinetics,
Cytori,
cytr,
cytrx,
Dendreon,
eurand,
FDA,
FDA Approvals,
Genzyme,
ILLUMINA,
Immunogen,
Insmed,
Intermune,
Iplex,
ISIS Pharmaceuticals,
Isis Pharmaceuticals,
Kystexxa,
LPath,
Micromet,
Onyx,
Onyx Pharmaceuticals,
OPTIMER,
osip,
Sangamo Biosciences,
savient,
Sequenom,
spectrum,
SQNM,
stem cells,
Tarceva,
xoma
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.














Full Index of Posts 14 posts, page 1 of 1
DENDREON (DNDN): Lessons from History
ADVENTRIX (ANX): A REVERSE SPLIT WITH SOME EXCITING NEWS.
ILLUMINA (ILMN): Today’s News Is What We Want To Hear.
Will LPATH (LPTN.OB) Reap the Fruits Of Its Acknowledged Efforts
ON SEQUENOM (SQNM)
OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.
CYTORI (CYTX): A STEM CELL HOPE FOR URINARY INCONTINENCE
XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM?
CYTRX (CYTR): NERVE REGENERATION TEN HOURS FOLLOWING A STROKE
SANGAMO BIOSCIENCES BIG NEWS
INSMED’S (INSM) DRUG IPLEX™: VALUABLE, OR NOT VALUABLE?
SAVIENT IS WORTH MUCH MORE THAN WHAT IS GOING ON
SAVIENT: WHY KRYSTEXXA’S REWARD OUTWEIGHS THE RISK?
SEQUENOM: WHY HAVE SHORT SELLERS PANICKED?